BRIEF-Trovagene announces submission of investigational NDA to initiate trial of PCM-075
* Trovagene announces submission of investigational new drug application to initiate phase 1B/2 clinical trial of PCM-075 for acute myeloid leukemia
May 4 Quest PharmaTech Inc:
* Says making a $500,000 cash investment to acquire 32% of outstanding common stock of Natural Rf Life Sciences Inc Source text for Eikon: Further company coverage:
* General Electric - awarded order from Consortium Duro Felguera (DF Energy) - Romelectro for technology in power plant from Romgaz in Iernut, Romania
June 27 Canada's Mandalay Resources Corp said efforts to locate two of its trapped miners in a flooded silver and gold mine in Chile were unsuccessful.